Claudia Maletzki

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

Top Venues

NPJ precision oncology

International journal of molecular sciences

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Said Kdimati, Clemens Christoph, Änne Glass, Nadja Engel, Desiree-Louise Dräger, Claudia Maletzki, Anne Sophie Becker, Annette Zimpfer
Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper Tract Urothelial Carcinoma. International journal of molecular sciences 25 (6) (2024)
Thomas Freitag, Philipp Kaps, Justus Ramtke, Sarah Bertels, Emily Zunke, Bjoern Schneider, Anne-Sophie Becker, Dirk Koczan, Daniel Dubinski, Thomas M Freiman, Felix Wittig, Burkhard Hinz, Mike-Andrew Westhoff, Hannah Strobel, Franziska Meiners, Daniel Wolter, Nadja Engel, Sascha Troschke-Meurer, Wendy Bergmann-Ewert, Susanne Staehlke, Annabell Wolff, Florian Gessler, Christian Junghanss, Claudia Maletzki
Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma. NPJ precision oncology 8 (1) (2024)
Said Kdimati, Clemens Christoph, Änne Glass, Nadja Engel, Desiree-Louise Dräger, Claudia Maletzki, Anne Sophie Becker, Annette Zimpfer
Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper Tract Urothelial Carcinoma. International journal of molecular sciences 25 (6) (2024)
Thomas Freitag, Philipp Kaps, Justus Ramtke, Sarah Bertels, Emily Zunke, Bjoern Schneider, Anne-Sophie Becker, Dirk Koczan, Daniel Dubinski, Thomas M Freiman, Felix Wittig, Burkhard Hinz, Mike-Andrew Westhoff, Hannah Strobel, Franziska Meiners, Daniel Wolter, Nadja Engel, Sascha Troschke-Meurer, Wendy Bergmann-Ewert, Susanne Staehlke, Annabell Wolff, Florian Gessler, Christian Junghanss, Claudia Maletzki
Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma. NPJ precision oncology 8 (1) (2024)
Thomas Freitag, Philipp Kaps, Justus Ramtke, Sarah Bertels, Emily Zunke, Bjoern Schneider, Anne-Sophie Becker, Dirk Koczan, Daniel Dubinski, Thomas M Freiman, Felix Wittig, Burkhard Hinz, Mike-Andrew Westhoff, Hannah Strobel, Franziska Meiners, Daniel Wolter, Nadja Engel, Sascha Troschke-Meurer, Wendy Bergmann-Ewert, Susanne Staehlke, Annabell Wolff, Florian Gessler, Christian Junghanss, Claudia Maletzki
Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma. NPJ precision oncology 8 (1) (2024)
Thomas Freitag, Philipp Kaps, Justus Ramtke, Sarah Bertels, Emily Zunke, Bjoern Schneider, Anne-Sophie Becker, Dirk Koczan, Daniel Dubinski, Thomas M Freiman, Felix Wittig, Burkhard Hinz, Mike-Andrew Westhoff, Hannah Strobel, Franziska Meiners, Daniel Wolter, Nadja Engel, Sascha Troschke-Meurer, Wendy Bergmann-Ewert, Susanne Staehlke, Annabell Wolff, Florian Gessler, Christian Junghanss, Claudia Maletzki
Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma. NPJ precision oncology 8 (1) (2024)
Said Kdimati, Clemens Christoph, Änne Glass, Nadja Engel, Desiree-Louise Dräger, Claudia Maletzki, Anne Sophie Becker, Annette Zimpfer
Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper Tract Urothelial Carcinoma. International journal of molecular sciences 25 (6) (2024)
Sascha Troschke-Meurer, Maxi Zumpe, Lena Meißner, Nikolai Siebert, Piotr Grabarczyk, Hannes Forkel, Claudia Maletzki, Sander Bekeschus, Holger N Lode
Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid Models. Cancers 15 (3) (2023)
Sarah Rehbein, Anna-Lena Possmayer, Süleyman Bozkurt, Catharina Lotsch, Julia Gerstmeier, Michael C Burger, Stefan Momma, Claudia Maletzki, Carl Friedrich Classen, Thomas M Freiman, Daniel Dubinski, Katrin Lamszus, Brett W Stringer, Christel Herold-Mende, Christian Münch, Donat Kögel, Benedikt Linder
Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells. Cancers 15 (21) (2023)
Claudia Maletzki, Vivica Freiin Grote, Friederike Kalle, Thoralf Kleitke, Annette Zimpfer, Anne-Sophie Becker, Wendy Bergmann-Ewert, Anika Jonitz-Heincke, Rainer Bader, Brigitte Vollmar, Stephan Hackenberg, Agmal Scherzad, Robert Mlynski, Daniel Strüder
Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction. Cell death discovery 9 (1) (2023)
Sascha Troschke-Meurer, Maxi Zumpe, Lena Meißner, Nikolai Siebert, Piotr Grabarczyk, Hannes Forkel, Claudia Maletzki, Sander Bekeschus, Holger N Lode
Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid Models. Cancers 15 (3) (2023)
Anne-Sophie Becker, Cornelius Kluge, Carsten Schofeld, Annette Helene Zimpfer, Bjoern Schneider, Daniel Strüder, Caterina Redwanz, Julika Ribbat-Idel, Christian Idel, Claudia Maletzki
Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers 15 (23) (2023)
Nina Schoenwaelder, Mareike Krause, Thomas Freitag, Bjoern Schneider, Sarah Zonnur, Annette Zimpfer, Anne Sophie Becker, Inken Salewski, Daniel Fabian Strüder, Heiko Lemcke, Christina Grosse-Thie, Christian Junghanss, Claudia Maletzki
Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches. Cancers 14 (10) (2022)
Christin Riess, Katharina Del Moral, Adina Fiebig, Philipp Kaps, Charlotte Linke, Burkhard Hinz, Anne Rupprecht, Marcus Frank, Tomas Fiedler, Dirk Koczan, Sascha Troschke-Meurer, Holger N Lode, Nadja Engel, Thomas Freitag, Carl Friedrich Classen, Claudia Maletzki
Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells. Cell death & disease 13 (6) (2022)
Inken Salewski, Julia Henne, Leonie Engster, Bjoern Schneider, Heiko Lemcke, Anna Skorska, Peggy Berlin, Larissa Henze, Christian Junghanss, Claudia Maletzki
Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors. International journal of molecular sciences 22 (11) (2021)
Nina Schoenwaelder, Inken Salewski, Nadja Engel, Mareike Krause, Bjoern Schneider, Michael Müller, Christin Riess, Heiko Lemcke, Anna Skorska, Christina Grosse-Thie, Christian Junghanss, Claudia Maletzki
The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells-A Systematic Analysis. Cancers 13 (10) (2021)
Christian Junghanss, Nina Schoenwaelder, Sina Sender, Christian Junghanss, Claudia Maletzki
Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies-Current Understanding, (Pre-)Clinical Application and Promising Approaches. Cancers 13 (10) (2021)
Daniel Strüder, Theresa Momper, Nina Irmscher, Mareike Krause, Jan Liese, Sebastian Schraven, Annette Zimpfer, Sarah Zonnur, Ann-Sophie Burmeister, Björn Schneider, Bernhard Frerich, Robert Mlynski, Christina Große-Thie, Christian Junghanss, Claudia Maletzki
Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Inken Salewski, Steffen Kuntoff, Andreas Kuemmel, Rico Feldtmann, Stephan B Felix, Larissa Henze, Christian Junghanss, Claudia Maletzki
Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors. Cancer immunology, immunotherapy : CII 70 (12) (2021)
Christin Riess, Dirk Koczan, Björn Schneider, Charlotte Linke, Katharina Del Moral, Carl Friedrich Classen, Claudia Maletzki
Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models. Cell death discovery 7 (1) (2021)
Inken Salewski, Yvonne Saara Gladbach, Steffen Kuntoff, Nina Irmscher, Olga Hahn, Christian Junghanss, Claudia Maletzki
In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters. Journal of translational medicine 18 (1) (2020)
Christin Riess, Nina Irmscher, Inken Salewski, Daniel Strüder, Carl-Friedrich Classen, Christina Große-Thie, Christian Junghanss, Claudia Maletzki
Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma-backbone or add-on in immune-oncology? Cancer metastasis reviews 40 (1) (2020)
Claudia Maletzki, Maja Hühns, Ingrid Bauer, Friedrich Prall, Christian Junghanss, Larissa Henze
Suspected Hereditary Cancer Syndromes in Young Patients: Heterogeneous Clinical and Genetic Presentation of Colorectal Cancers. The oncologist 24 (7) (2019)
Claudia Maletzki, Philine Scheinpflug, Anika Witt, Ernst Klar, Michael Linnebacher
Targeting Immune-Related Molecules in Cancer Therapy: A Comprehensive In Vitro Analysis on Patient-Derived Tumor Models. BioMed research international 2019 (2019)
Claudia Maletzki, Stephanie Bock, Philipp Fruh, Karolis Macius, Anika Witt, Friedrich Prall, Michael Linnebacher
NSG mice as hosts for oncological precision medicine. Laboratory investigation; a journal of technical methods and pathology 100 (1) (2019)
Claudia Maletzki, Leonie Wiegele, Ingy Nassar, Jan Stenzel, Christian Junghanss
Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer. Journal for immunotherapy of cancer 7 (1) (2019)
Claudia Maletzki, Maja Huehns, Ingrid Bauer, Tim Ripperger, Maureen M Mork, Eduardo Vilar, Sabine Klöcking, Heike Zettl, Friedrich Prall, Michael Linnebacher
Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome. Molecular carcinogenesis 56 (7) (2017)